756 related articles for article (PubMed ID: 33222462)
1. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study.
Zhao B; Ling Y; Li J; Peng Y; Huang J; Wang Y; Qu H; Gao Y; Li Y; Hu B; Lu S; Lu H; Zhang W; Mao E
Ann Palliat Med; 2021 Feb; 10(2):1599-1609. PubMed ID: 33222462
[TBL] [Abstract][Full Text] [Related]
2. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study.
Zhao B; Liu M; Liu P; Peng Y; Huang J; Li M; Wang Y; Xu L; Sun S; Qi X; Ling Y; Li J; Zhang W; Mao E; Qu J
Front Pharmacol; 2021; 12():638556. PubMed ID: 33967773
[No Abstract] [Full Text] [Related]
3. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients.
Zhang J; Rao X; Li Y; Zhu Y; Liu F; Guo G; Luo G; Meng Z; De Backer D; Xiang H; Peng Z
Ann Intensive Care; 2021 Jan; 11(1):5. PubMed ID: 33420963
[TBL] [Abstract][Full Text] [Related]
4. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
JamaliMoghadamSiahkali S; Zarezade B; Koolaji S; SeyedAlinaghi S; Zendehdel A; Tabarestani M; Sekhavati Moghadam E; Abbasian L; Dehghan Manshadi SA; Salehi M; Hasannezhad M; Ghaderkhani S; Meidani M; Salahshour F; Jafari F; Manafi N; Ghiasvand F
Eur J Med Res; 2021 Feb; 26(1):20. PubMed ID: 33573699
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
Kwak SG; Choo YJ; Chang MC
Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19.
Hess AL; Halalau A; Dokter JJ; Paydawy TS; Karabon P; Bastani A; Baker RE; Balla AK; Galens SA
Intern Emerg Med; 2022 Sep; 17(6):1759-1768. PubMed ID: 35349005
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vitamin C on mortality of critically ill patients with severe pneumonia in intensive care unit: a preliminary study.
Mahmoodpoor A; Shadvar K; Sanaie S; Hadipoor MR; Pourmoghaddam MA; Saghaleini SH
BMC Infect Dis; 2021 Jun; 21(1):616. PubMed ID: 34187382
[TBL] [Abstract][Full Text] [Related]
8. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study.
Gao D; Xu M; Wang G; Lv J; Ma X; Guo Y; Zhang D; Yang H; Jiang W; Deng F; Xia G; Lu Z; Lv L; Gong S
Aging (Albany NY); 2021 Feb; 13(5):7020-7034. PubMed ID: 33638944
[TBL] [Abstract][Full Text] [Related]
9. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
10. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial.
Beigmohammadi MT; Bitarafan S; Hoseindokht A; Abdollahi A; Amoozadeh L; Mahmoodi Ali Abadi M; Foroumandi M
Trials; 2020 Jul; 21(1):614. PubMed ID: 32631405
[TBL] [Abstract][Full Text] [Related]
11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
14. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial.
Fujii T; Luethi N; Young PJ; Frei DR; Eastwood GM; French CJ; Deane AM; Shehabi Y; Hajjar LA; Oliveira G; Udy AA; Orford N; Edney SJ; Hunt AL; Judd HL; Bitker L; Cioccari L; Naorungroj T; Yanase F; Bates S; McGain F; Hudson EP; Al-Bassam W; Dwivedi DB; Peppin C; McCracken P; Orosz J; Bailey M; Bellomo R;
JAMA; 2020 Feb; 323(5):423-431. PubMed ID: 31950979
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic data support 6-hourly dosing of intravenous vitamin C to critically ill patients with septic shock.
Hudson EP; Collie JT; Fujii T; Luethi N; Udy AA; Doherty S; Eastwood G; Yanase F; Naorungroj T; Bitker L; Abdelhamid YA; Greaves RF; Deane AM; Bellomo R
Crit Care Resusc; 2019 Dec; 21(4):236-42. PubMed ID: 31778629
[TBL] [Abstract][Full Text] [Related]
16. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial.
Fowler AA; Truwit JD; Hite RD; Morris PE; DeWilde C; Priday A; Fisher B; Thacker LR; Natarajan R; Brophy DF; Sculthorpe R; Nanchal R; Syed A; Sturgill J; Martin GS; Sevransky J; Kashiouris M; Hamman S; Egan KF; Hastings A; Spencer W; Tench S; Mehkri O; Bindas J; Duggal A; Graf J; Zellner S; Yanny L; McPolin C; Hollrith T; Kramer D; Ojielo C; Damm T; Cassity E; Wieliczko A; Halquist M
JAMA; 2019 Oct; 322(13):1261-1270. PubMed ID: 31573637
[TBL] [Abstract][Full Text] [Related]
17. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
[TBL] [Abstract][Full Text] [Related]
18. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial.
Majidi N; Rabbani F; Gholami S; Gholamalizadeh M; BourBour F; Rastgoo S; Hajipour A; Shadnoosh M; Akbari ME; Bahar B; Ashoori N; Alizadeh A; Samipoor F; Moslem A; Doaei S; Suzuki K
Front Immunol; 2021; 12():717816. PubMed ID: 34975830
[TBL] [Abstract][Full Text] [Related]
20. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
